Ren X, Wang J, Osada T, Mook RA, Morse MA, Barak LS, Lyerly HK, Chen W
Breast cancer research - vol. 17 1-11 (2015)
INTRODUCTION: Human epidermal growth factor receptor HER3 has been implicated in promoting the aggressiveness and metastatic potential of breast cancer. Upregulation of HER3 has been found to be a major mechanism underlying drug resistance to EGFR and HER2 tyrosine kinase inhibitors and to endocrine therapy in the treatment of breast cancer. Thus, agents that reduce […]